Effect of adjuvant radioactive iodine therapy on survival in rare oxyphilic subtype of thyroid cancer (Hürthle cell carcinoma)
Purpose Radioactive iodine (RAI) is widely used for adjuvant therapy after thyroidectomy, while its value for thyroid cancer has been controversial recently. The primary objectives of this study were to clarify the influence of Radioactive iodine (RAI) on the survival in rare oxyphilic subtype of th...
Main Authors: | Qiong Yang, Zhongsheng Zhao, Guansheng Zhong, Aixiang Jin, Kun Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
PeerJ Inc.
2019-08-01
|
Series: | PeerJ |
Subjects: | |
Online Access: | https://peerj.com/articles/7458.pdf |
Similar Items
-
Thyroid Hürthle Cell Carcinoma: Clinical, Pathological, and Molecular Features
by: Shoko Kure, et al.
Published: (2020-12-01) -
Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid
by: Machado José, et al.
Published: (2004-03-01) -
Low Iodine Diet for Preparation for Radioactive Iodine Therapy in Differentiated Thyroid Carcinoma in Korea
by: Jae Hoon Chung
Published: (2013-09-01) -
Management of hyperthyroidism with radioactive iodine
by: T Premprapha, et al.
Published: (2006-08-01) -
Usability of EU-TIRADS in the Diagnostics of Hürthle Cell Thyroid Nodules with Equivocal Cytology
by: Dorota Słowińska-Klencka, et al.
Published: (2020-10-01)